These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2538099)

  • 21. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy.
    Jones EA
    Metab Brain Dis; 2002 Dec; 17(4):275-81. PubMed ID: 12602504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.
    Mullen KD; Martin JV; Mendelson WB; Kaminsky-Russ K; Jones EA
    Metab Brain Dis; 1989 Dec; 4(4):253-60. PubMed ID: 2557531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.
    Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H
    Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF
    Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy.
    Mullen KD; Szauter KM; Kaminsky-Russ K
    Lancet; 1990 Jul; 336(8707):81-3. PubMed ID: 1975325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.
    Maddison JE; Dodd PR; Morrison M; Johnston GA; Farrell GC
    Hepatology; 1987; 7(4):621-8. PubMed ID: 3038721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2005 Dec; 20(4):425-37. PubMed ID: 16382352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
    Ahboucha S; Araqi F; Layrargues GP; Butterworth RF
    Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-aminobutyric acid (GABAA) receptor-function in a rat model of hepatic encephalopathy.
    Baker BL; Morrow AL; Vergalla J; Paul SM; Jones EA
    Metab Brain Dis; 1990 Dec; 5(4):185-93. PubMed ID: 1965008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The GABAA receptor complex in hepatic encephalopathy. Autoradiographic evidence for the presence of elevated levels of a benzodiazepine receptor ligand.
    Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P
    Neuropsychopharmacology; 1990 Feb; 3(1):61-71. PubMed ID: 2154999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract]   [Full Text] [Related]  

  • 34. The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy.
    Basile AS
    Synapse; 1991 Feb; 7(2):141-50. PubMed ID: 1849322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theories of the pathogenesis of hepatic encephalopathy.
    Jones EA; Mullen KD
    Clin Liver Dis; 2012 Feb; 16(1):7-26. PubMed ID: 22321462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy.
    Rössle M; Deckert J; Jones EA
    Hepatology; 1989 Aug; 10(2):143-7. PubMed ID: 2545587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA; Basile AS; Yurdaydin C; Skolnich P
    Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proposed therapy for the encephalopathies of Reye's syndrome and hepatic encephalopathy.
    Anderson B
    Med Hypotheses; 1984 Dec; 15(4):415-20. PubMed ID: 6098803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.
    Zieve L; Ferenci P; Rzepczynski D; Ebner J; Zimmermann C
    Metab Brain Dis; 1987 Sep; 2(3):201-5. PubMed ID: 2850457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.